Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate Cancer
Clinical trial NCT02833883 · COMPLETED
Trial details
- NCT number
- NCT02833883
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2023-01-13
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.